136 related articles for article (PubMed ID: 11229781)
1. Controlled drug release: new water-soluble prodrugs of an HIV protease inhibitor.
Matsumoto H; Sohma Y; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2001 Feb; 11(4):605-9. PubMed ID: 11229781
[TBL] [Abstract][Full Text] [Related]
2. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
3. New water-soluble prodrugs of HIV protease inhibitors based on O-->N intramolecular acyl migration.
Hamada Y; Ohtake J; Sohma Y; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem; 2002 Dec; 10(12):4155-67. PubMed ID: 12413869
[TBL] [Abstract][Full Text] [Related]
4. Water-soluble prodrugs of dipeptide HIV protease inhibitors based on O-->N intramolecular acyl migration: Design, synthesis and kinetic study.
Hamada Y; Matsumoto H; Yamaguchi S; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem; 2004 Jan; 12(1):159-70. PubMed ID: 14697781
[TBL] [Abstract][Full Text] [Related]
5. Effect of the acyl groups on O-->N acyl migration in the water-soluble prodrugs of HIV-1 protease inhibitor.
Hamada Y; Matsumoto H; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2003 Aug; 13(16):2727-30. PubMed ID: 12873502
[TBL] [Abstract][Full Text] [Related]
6. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
[TBL] [Abstract][Full Text] [Related]
7. No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: scope and limitation of O-N intramolecular acyl and acyloxy migration reactions.
Skwarczynski M; Sohma Y; Noguchi M; Kimura M; Hayashi Y; Hamada Y; Kimura T; Kiso Y
J Med Chem; 2005 Apr; 48(7):2655-66. PubMed ID: 15801856
[TBL] [Abstract][Full Text] [Related]
8. Novel prodrug approach to amprenavir-based HIV-1 protease inhibitors via O-->N acyloxy migration of P1 moiety.
Kazmierski WM; Bevans P; Furfine E; Spaltenstein A; Yang H
Bioorg Med Chem Lett; 2003 Aug; 13(15):2523-6. PubMed ID: 12852957
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro biological evaluation of valine-containing prodrugs derived from clinically used HIV-protease inhibitors.
Roche D; Greiner J; Aubertin AM; Vierling P
Eur J Med Chem; 2008 Jul; 43(7):1506-18. PubMed ID: 17950955
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir.
A M Subbaiah M; Mandlekar S; Desikan S; Ramar T; Subramani L; Annadurai M; Desai SD; Sinha S; Jenkins SM; Krystal MR; Subramanian M; Sridhar S; Padmanabhan S; Bhutani P; Arla R; Singh S; Sinha J; Thakur M; Kadow JF; Meanwell NA
J Med Chem; 2019 Apr; 62(7):3553-3574. PubMed ID: 30938524
[TBL] [Abstract][Full Text] [Related]
11. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
[TBL] [Abstract][Full Text] [Related]
12. 'Double-Drugs'--a new class of prodrug form of an HIV protease inhibitor conjugated with a reverse transcriptase inhibitor by a spontaneously cleavable linker.
Matsumoto H; Hamawaki T; Ota H; Kimura T; Goto T; Sano K; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2000 Jun; 10(11):1227-31. PubMed ID: 10866387
[TBL] [Abstract][Full Text] [Related]
13. Water-soluble prodrugs of the human immunodeficiency virus protease inhibitors lopinavir and ritonavir.
DeGoey DA; Grampovnik DJ; Flosi WJ; Marsh KC; Wang XC; Klein LL; McDaniel KF; Liu Y; Long MA; Kati WM; Molla A; Kempf DJ
J Med Chem; 2009 May; 52(9):2964-70. PubMed ID: 19348416
[TBL] [Abstract][Full Text] [Related]
14. Water-soluble prodrugs of cyclosporine A with tailored conversion rates.
Hamel AR; Hubler F; Mutter M
J Pept Res; 2005 Mar; 65(3):364-74. PubMed ID: 15787967
[TBL] [Abstract][Full Text] [Related]
15. Novel prodrugs with a spontaneous cleavable guanidine moiety.
Hamada Y
Bioorg Med Chem Lett; 2016 Apr; 26(7):1685-9. PubMed ID: 26923694
[TBL] [Abstract][Full Text] [Related]
16. Peptide prodrugs: improved oral absorption of lopinavir, a HIV protease inhibitor.
Agarwal S; Boddu SH; Jain R; Samanta S; Pal D; Mitra AK
Int J Pharm; 2008 Jul; 359(1-2):7-14. PubMed ID: 18455890
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, chemical and enzymatic hydrolysis, and bioavailability evaluation in rabbits of metronidazole amino acid ester prodrugs with enhanced water solubility.
Mahfouz NM; Hassan MA
J Pharm Pharmacol; 2001 Jun; 53(6):841-8. PubMed ID: 11428660
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro biological evaluation of mannose-containing prodrugs derived from clinically used HIV-protease inhibitors with improved transepithelial transport.
Roche D; Greiner J; Aubertin AM; Vierling P
Bioconjug Chem; 2006; 17(6):1568-81. PubMed ID: 17105238
[TBL] [Abstract][Full Text] [Related]
19. Solubilization of a tripeptide HIV protease inhibitor using a combination of ionization and complexation with chemically modified cyclodextrins.
Johnson MD; Hoesterey BL; Anderson BD
J Pharm Sci; 1994 Aug; 83(8):1142-6. PubMed ID: 7983599
[TBL] [Abstract][Full Text] [Related]
20. Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release.
de Groot FM; Loos WJ; Koekkoek R; van Berkom LW; Busscher GF; Seelen AE; Albrecht C; de Bruijn P; Scheeren HW
J Org Chem; 2001 Dec; 66(26):8815-30. PubMed ID: 11749612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
